Targeting Hepatitis B Virus DNA Using Designer Gene Editors.
Clin Liver Dis
; 27(4): 895-916, 2023 11.
Article
em En
| MEDLINE
| ID: mdl-37778776
ABSTRACT
Chronic hepatitis B virus (HBV) infection is a serious disease that currently has no cure. Key forms of HBV include covalently closed circular DNA, which mediates chronic persistence, and integrated DNA, which contributes to immune evasion and carcinogenesis. These forms are not targeted by current therapies; however, gene editing technologies have emerged as promising tools for disrupting HBV DNA. Gene editor-induced double-stranded breaks at precise locations within the HBV genome can induce effects ranging from inactivation of target genes to complete degradation of the target genome. Although promising, several challenges remain in efficacy and safety that require solutions.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vírus da Hepatite B
/
Hepatite B Crônica
/
Hepatite B
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article